Clinical Trial Update: Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)

View source ↗

Summary

A clinical trial comparing single or repeated zoledronic acid to alendronate following denosumab in postmenopausal osteoporosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Zoledronic acid (Zoledronic acid)
• alendronate (alendronate)

Snippet

Sponsor: 424 General Military Hospital | Conditions: Osteoporosis, Postmenopausal | Status: RECRUITING